Home/Publication/IDG Leads in Vaccines Development
IDG Leads in Vaccines Development 

04 Jul 2024

US$ 19.00

IDG Capital has led in the over Rmb300 million (US$41.3 million) series C+ funding round of Chengdu Maxvax ......

Price / article: US$19.00
OR existing subscriber
Related Publications

Manus, the Singapore-headquartered Chinese AI company which was acquired by Meta Platforms Inc (Meta) in ......

Indonesia’s sovereign wealth fund, Danantara Indonesia (Danantara), is expanding its overseas asset base and forging ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.